IL195412A0 - Methods and compositions using immunomodulatory compounds in combination therapy - Google Patents
Methods and compositions using immunomodulatory compounds in combination therapyInfo
- Publication number
- IL195412A0 IL195412A0 IL195412A IL19541208A IL195412A0 IL 195412 A0 IL195412 A0 IL 195412A0 IL 195412 A IL195412 A IL 195412A IL 19541208 A IL19541208 A IL 19541208A IL 195412 A0 IL195412 A0 IL 195412A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- combination therapy
- immunomodulatory compounds
- immunomodulatory
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80860206P | 2006-05-26 | 2006-05-26 | |
| PCT/US2007/012495 WO2007139939A2 (en) | 2006-05-26 | 2007-05-24 | Methods and compositions using immunomodulatory compounds in combination therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL195412A0 true IL195412A0 (en) | 2009-08-03 |
Family
ID=38606531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL195412A IL195412A0 (en) | 2006-05-26 | 2008-11-20 | Methods and compositions using immunomodulatory compounds in combination therapy |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2023912A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009538318A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090014393A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101495111A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007267928A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2652888A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL195412A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008014912A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2426542C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007139939A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200809956B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101977603A (zh) * | 2008-01-29 | 2011-02-16 | 细胞基因公司 | 使用免疫调节化合物来调节cd59水平的方法 |
| WO2013142817A2 (en) * | 2012-03-23 | 2013-09-26 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| EP3623011B1 (en) * | 2013-08-22 | 2025-02-12 | Vanda Pharmaceuticals Inc. | Trichostatin a for use in multiple myeloma treatment |
| JP2016528297A (ja) | 2013-08-22 | 2016-09-15 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | 癌治療 |
| CN106455542A (zh) * | 2014-03-26 | 2017-02-22 | 布里格姆及妇女医院股份有限公司 | 用于人造血干/祖细胞的离体扩增的组合物和方法 |
| WO2015175916A1 (en) * | 2014-05-16 | 2015-11-19 | Celgene Corporation | Methods and compositions using 4-amino-2-(2,6 dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment of cancers |
| EP4396331A1 (en) * | 2021-09-01 | 2024-07-10 | Flagship Pioneering Innovations VI, LLC | Methods and compositions for inducing fetal hemoglobin, modulating erythroid cell lineages, and perturbing megakaryocyte lineages |
| CN120129677A (zh) | 2022-11-04 | 2025-06-10 | 百时美施贵宝公司 | 化合物及其用于治疗血红素病变的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| DK1505973T3 (da) * | 2002-05-17 | 2010-05-31 | Celgene Corp | Kombinationer til behandling af multipelt myelom |
| KR20050057672A (ko) * | 2002-10-24 | 2005-06-16 | 셀진 코포레이션 | 통증의 치료, 변형 및 관리를 위한 면역조절 화합물을포함하는 조성물 및 이의 사용 방법 |
| US7563810B2 (en) * | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
| US20050043233A1 (en) * | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| BRPI0417186A (pt) * | 2003-12-02 | 2007-03-06 | Celgene Corp | método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica |
| US20060058311A1 (en) * | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
-
2007
- 2007-05-24 KR KR1020087031357A patent/KR20090014393A/ko not_active Withdrawn
- 2007-05-24 MX MX2008014912A patent/MX2008014912A/es not_active Application Discontinuation
- 2007-05-24 EP EP07795353A patent/EP2023912A2/en not_active Withdrawn
- 2007-05-24 WO PCT/US2007/012495 patent/WO2007139939A2/en not_active Ceased
- 2007-05-24 RU RU2008151713/15A patent/RU2426542C2/ru not_active IP Right Cessation
- 2007-05-24 CN CNA2007800277224A patent/CN101495111A/zh active Pending
- 2007-05-24 ZA ZA200809956A patent/ZA200809956B/xx unknown
- 2007-05-24 CA CA002652888A patent/CA2652888A1/en not_active Abandoned
- 2007-05-24 JP JP2009512164A patent/JP2009538318A/ja active Pending
- 2007-05-24 AU AU2007267928A patent/AU2007267928A1/en not_active Abandoned
-
2008
- 2008-11-20 IL IL195412A patent/IL195412A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007267928A1 (en) | 2007-12-06 |
| WO2007139939A2 (en) | 2007-12-06 |
| KR20090014393A (ko) | 2009-02-10 |
| CN101495111A (zh) | 2009-07-29 |
| ZA200809956B (en) | 2010-07-28 |
| JP2009538318A (ja) | 2009-11-05 |
| EP2023912A2 (en) | 2009-02-18 |
| MX2008014912A (es) | 2008-12-10 |
| RU2426542C2 (ru) | 2011-08-20 |
| CA2652888A1 (en) | 2007-12-06 |
| WO2007139939A3 (en) | 2008-07-03 |
| RU2008151713A (ru) | 2010-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191072A0 (en) | Therapeutic compositions and methods | |
| EP2180873A4 (en) | THERAPEUTIC DENTAL COMPOSITION AND RELATED METHODS | |
| EP2182922A4 (en) | ANTIGEN-ADJUVANS COMPOSITIONS AND METHOD | |
| ZA201203709B (en) | Immunogenic compositions and methods | |
| IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
| PL3263581T5 (pl) | Kompozycje i sposoby immunomodulacji w organizmie | |
| PL2705826T3 (pl) | Kompozycja fluorku i sposoby mineralizacji zębów | |
| IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
| GB0721291D0 (en) | Methods and compositions | |
| IL247957A0 (en) | Anti-ephrinb2 antibodies and methods of using them | |
| IL194826A0 (en) | Compositions and methods for cellular imaging and therapy | |
| ZA200809956B (en) | Methods and compositions using Immunomodulatory compounds in combination therapy | |
| PL2012805T3 (pl) | Kompozycja lecznicza i jej zastosowanie | |
| IL196411A0 (en) | Anti-cocaine compositions and treatment | |
| GB0719526D0 (en) | Compositions and methods | |
| EP2083755A4 (en) | MEDICAL KIT AND METHOD THEREFOR | |
| EP2097085A4 (en) | THERAPEUTIC MATERIALS AND METHOD | |
| GB0617171D0 (en) | Novel compositions and methods | |
| GB0714500D0 (en) | composition and treatment | |
| GB0501348D0 (en) | Compositions and methods | |
| GB0517546D0 (en) | Therapeutic methods and compositions | |
| GB0616269D0 (en) | Methods and compositions | |
| GB0625230D0 (en) | Compositions and methods | |
| GB0607565D0 (en) | Methods and compositions | |
| GB0418363D0 (en) | Therapeutic methods and compositions for use therein |